Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy—a tertiary centre experience in an Appalachian state

ED McVeigh, A Batool, A Stromberg… - Lupus Science & …, 2021 - lupus.bmj.com
Objectives Cardiovascular complications became a notable cause of morbidity and mortality
in patients with lupus as therapeutic advancements became more efficient at managing …

Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease

B Weber, KP Liao, M DiCarli… - Current opinion in …, 2021 - journals.lww.com
A comprehensive approach that includes cardiovascular risk factor modification, control of
systemic inflammation, and increased patient and physician awareness is needed in …

[HTML][HTML] Impaired arterial stiffness in systemic lupus ertythematosus-correlations with inflammation markers

AL Barbulescu, F Vreju, IR Cojocaru-Gofita… - Current health …, 2012 - ncbi.nlm.nih.gov
Background: Systemic lupus erythematosus (SLE) is an inflammatory disease caused by
autoimmune dysregulation, which mainly affects young women, usually free from …

Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus

XY Wang, XQ Tang, YJ Huang, WY Chen, XQ Yu - Clinical rheumatology, 2012 - Springer
Cardiovascular disease (CVD) is one of the most serious complications of systemic lupus
erythematosus (SLE). This study investigated the frequency of established CVD and its …

Imaging assessment of cardiovascular disease in systemic lupus erythematosus

SC Croca, A Rahman - Journal of Immunology Research, 2012 - Wiley Online Library
Systemic lupus erythematosus is a multisystem, autoimmune disease known to be one of the
strongest risk factors for atherosclerosis. Patients with SLE have an excess cardiovascular …

Autoimmune diseases, their pharmacological treatment and the cardiovascular system

M Jastrzębska, ME Czok, P Guzik - Cardiology journal, 2013 - journals.viamedica.pl
Cardiovascular system involvement is a frequent complication of autoimmune diseases (AD)
such as systemic lupus erythematosus, scleroderma, rheumatoid arthritis …

TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

DR Fajar, T Rostinawati, L Hamijoyo… - … : Targets and Therapy, 2024 - Taylor & Francis
Background Systemic lupus erythematosus (SLE) is a complex autoimmune disease with
numerous clinical manifestations. Organ involvement can aggravate patients with SLE and …

The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE−/− Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus

C Richez, RJ Richards, P Duffau, Z Weitzner… - PLoS …, 2013 - journals.plos.org
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is characterized
by autoantibody production and inflammatory disease involving multiple organs. Premature …

Blood pressure control over time in childhood-onset systemic lupus erythematous

PO Avar Aydin, J Shan, HI Brunner, MM Mitsnefes - Lupus, 2018 - journals.sagepub.com
Introduction Hypertension (HTN) is prevalent in patients with systemic lupus erythematosus
(SLE) and causes early cardiovascular aging and progression of renal and cardiac disease …

Myocarditis and autoimmunity

A Matsumori - Expert Review of Cardiovascular Therapy, 2023 - Taylor & Francis
Introduction Autoimmune myocarditis may develop due to heterogeneous causes.
Myocarditis is often caused by viral infections, but it can also be caused by systemic …